betadex and benzonidazole

betadex has been researched along with benzonidazole* in 3 studies

Other Studies

3 other study(ies) available for betadex and benzonidazole

ArticleYear
First solid-state NMR spectroscopy evaluation of complexes of benznidazole with cyclodextrin derivatives.
    Carbohydrate polymers, 2015, Oct-20, Volume: 131

    Complexation of benznidazole (BZL), a drug of choice for the treatment of Chagas'neglected disease, with cyclodextrin (CD) derivatives was analyzed by solid-state NMR. (13)C cross polarization/magic angle spinning spectra were recorded from BZL and from BZL:β-CD, BZL:methyl β-CD and BZL:hydroxypropyl β-CD complexes, which were obtained by the solvent evaporation technique. No significant evidence was obtained on BZL inclusion complexes involving either β-CD or hydroxypropyl β-CD. Conversely, BZL:methyl β-CD displayed BZL resonances characteristic of an amorphous drug and data analysis confirmed the presence of stable BZL:methyl β-CD inclusion complexes, with benzene encapsulated into the host cavity. Further evidences on complex structure and dynamics were obtained from proton and carbon spin-lattice relaxation times in the rotating frame. These data are consistent with a common guest-host spin reservoir. The BZL interaction with methyl β-CD provided a route to stabilize amorphous BZL. Physical mixtures with identical BZL and CD compositions were also studied for comparison.

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Carbon; Carbon-13 Magnetic Resonance Spectroscopy; Cyclodextrins; Nitroimidazoles; Protons; Time Factors

2015
Benznidazole drug delivery by binary and multicomponent inclusion complexes using cyclodextrins and polymers.
    Carbohydrate polymers, 2012, Jun-20, Volume: 89, Issue:2

    Benznidazole (BNZ) is the drug of choice for Chagas disease treatment, which affects about 9.8 million people worldwide. It has low solubility and high toxicity. The present study aimed to develop and characterize inclusion complexes (IC) in binary systems (BS) with BNZ and randomly methylated-β-cyclodextrin (RMβCD) and in ternary systems (TS) with BNZ, RMβCD and hydrophilic polymers. The results showed that the solid BS had a large increase in dissolution rate (Q>80%). For the solid IC obtained, the kneading method, in ratio of 1:0.17 (77.8% in 60 min), appeared to be the most suitable for the development of a solid oral pharmaceutical product, with possible industrial scale-up and low concentration of CD. The solid TS containing 0.1% of hydroxypropylmethylcellulose (HPMC) showed no significant advantages compared to the binary IC in solid state. The use of cyclodextrins proved to be a viable tool for effective, standardized and safe drug delivery.

    Topics: beta-Cyclodextrins; Drug Delivery Systems; Hydrophobic and Hydrophilic Interactions; Hypromellose Derivatives; Methylation; Nitroimidazoles; Povidone; Solubility; Trypanocidal Agents

2012
Development of effervescent tablets containing benzonidazole complexed with cyclodextrin.
    The Journal of pharmacy and pharmacology, 2011, Volume: 63, Issue:6

    Benznidazole (BNZ), the primary chemotherapy agent used to treat Chagas disease, has poor aqueous solubility, which results in low bioavailability. The purpose of this work was to develop stable effervescent tablets using an inclusion complex of BNZ with cyclodextrin (CD).. In the first phase, different CDs were evaluated according to their ability to improve the aqueous solubility of BNZ. Then, inclusion complexes of BNZ in the solid state were produced by the kneading method and the complexes were evaluated using several physical-chemical assays. Finally, effervescent tablets were prepared according to a complete 3(2) factorial design. The effects of the concentration of CD and effervescent mixture on the dissolution rate and physical stability of tablets were evaluated.. Hydroxypropyl-β-cyclodextrin produced the greatest improvement in the aqueous solubility of BNZ, almost 20-times greater than the water system. Solid systems produced with BNZ and CD showed physical-chemical interactions and increased the drug dissolution rate, suggesting the formation of a true solid inclusion complex. Moreover, the effervescent matrix of the tablets was effective in improving the dissolution behaviour of BNZ complexed with CD.. Effervescent tablets produced using an inclusion complex of BNZ with CD suggest a possible improvement in the bioavailability of BNZ, and this could represent a relevant advance in Chagas therapy.

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Biological Availability; Chagas Disease; Hydrophobic and Hydrophilic Interactions; Nitroimidazoles; Solubility; Tablets; Technology, Pharmaceutical; Water

2011